Background and Aims. There is no consensus so far regarding the optimal endoscopic method for treatment of small rectal neuroendocrine tumor (NET). The aim of this study was to compare treatment efficacy, safety, and procedure time between endoscopic submucosal resection with band ligation (ESMR-L) and endoscopic submucosal dissection (ESD). Methods. We conducted a prospective study of patients who visited Inha University Hospital for endoscopic resection of rectal NET (≦10 mm). Pathological complete resection rate, procedure time, and complications were evaluated. Results. A total of 77 patients were treated by ESMR-L (n=53) or ESD (n=24). En bloc resection was achieved in all patients. A significantly higher pathological complete resectio...
Purpose: The management of small (≤5 mm) rectal neuroendocrine neoplasms (r-NENs), incidentally remo...
Background and Aims. Conventional endoscopic submucosal resection (EMR) of carcinoid tumors often in...
Rectal neuroendocrine tumors (NETs) are rare, with an incidence of 0.17%, but they represent 12% to ...
Background/Aims: Ligation-assisted endoscopic submucosal resection (ESMR-L) is preferred for the tre...
Background and Aim: Among various endoscopic resection therapies, including conventional endoscopic ...
The incidence of rectal neuroendocrine tumors (NETs) has increased by almost ten-fold over the past ...
Purpose Local treatment of small well-differentiated rectal neuroendocrine tumors (NETs) is recomme...
Background/Aims Endoscopic resection is the first-line treatment for rectal neuroendocrine tumors (N...
Generally, lesions of rectal neuroendocrine tumors (NETs) 10 mm or smaller are less malignant and ar...
Introduction : A significant rise in incidence of rectal gastroenteropancreatic neuroendocrine neopl...
Abstract Small rectal neuroendocrine tumors (NETs) can be treated using cap-assisted endoscopic muco...
Background/AimsRectal neuroendocrine tumors (NETs) are among the most common of gastrointestinal NET...
International audienceINTRODUCTION:Small rectal neuroendocrine tumours are good candidates for endos...
AbstractPurpose To compare the effectiveness, safety and cost-effectiveness of endoscopic submucosal...
Abstract Background The incidence of rectal neuroendocrine tumors (NETs) is rapidly increasing becau...
Purpose: The management of small (≤5 mm) rectal neuroendocrine neoplasms (r-NENs), incidentally remo...
Background and Aims. Conventional endoscopic submucosal resection (EMR) of carcinoid tumors often in...
Rectal neuroendocrine tumors (NETs) are rare, with an incidence of 0.17%, but they represent 12% to ...
Background/Aims: Ligation-assisted endoscopic submucosal resection (ESMR-L) is preferred for the tre...
Background and Aim: Among various endoscopic resection therapies, including conventional endoscopic ...
The incidence of rectal neuroendocrine tumors (NETs) has increased by almost ten-fold over the past ...
Purpose Local treatment of small well-differentiated rectal neuroendocrine tumors (NETs) is recomme...
Background/Aims Endoscopic resection is the first-line treatment for rectal neuroendocrine tumors (N...
Generally, lesions of rectal neuroendocrine tumors (NETs) 10 mm or smaller are less malignant and ar...
Introduction : A significant rise in incidence of rectal gastroenteropancreatic neuroendocrine neopl...
Abstract Small rectal neuroendocrine tumors (NETs) can be treated using cap-assisted endoscopic muco...
Background/AimsRectal neuroendocrine tumors (NETs) are among the most common of gastrointestinal NET...
International audienceINTRODUCTION:Small rectal neuroendocrine tumours are good candidates for endos...
AbstractPurpose To compare the effectiveness, safety and cost-effectiveness of endoscopic submucosal...
Abstract Background The incidence of rectal neuroendocrine tumors (NETs) is rapidly increasing becau...
Purpose: The management of small (≤5 mm) rectal neuroendocrine neoplasms (r-NENs), incidentally remo...
Background and Aims. Conventional endoscopic submucosal resection (EMR) of carcinoid tumors often in...
Rectal neuroendocrine tumors (NETs) are rare, with an incidence of 0.17%, but they represent 12% to ...